ArticleOncogene2002
The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug target.
Yoshihiro Yamada et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this papercites it
ArticleOncogene2002
Yoshihiro Yamada et al.PubMed ↗Publisher ↗
No numbers read from the abstract.